A Single-Center, Multiple-dose, Randomized, Cross-Over, Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacodynamics, Safety, and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study
Phase of Trial: Phase I/II
Latest Information Update: 17 Jun 2013
Price : $35 *
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 30 Jan 2013 New trial record